Publications in collaboration with researchers from University of Florence (40)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Clinical-Hematological Changes and Predictors of Severity in Acute Food Protein–Induced Enterocolitis Syndrome Reactions at Oral Food Challenge: A Multicenter Observational Study

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 12, Núm. 9, pp. 2454-2467.e8

  3. Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.

    New England Journal of Medicine, Vol. 390, Núm. 4, pp. 301-313

2023

  1. Benign descriptors and ADNEX in two-step strategy to estimate risk of malignancy in ovarian tumors: retrospective validation in IOTA5 multicenter cohort

    Ultrasound in Obstetrics and Gynecology, Vol. 61, Núm. 2, pp. 231-242

  2. Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma

    Frontiers in Endocrinology, Vol. 13

  3. Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)

    Leukemia

  4. External Validation of the Ovarian-Adnexal Reporting and Data System (O-RADS) Lexicon and the International Ovarian Tumor Analysis 2-Step Strategy to Stratify Ovarian Tumors into O-RADS Risk Groups

    JAMA Oncology, Vol. 9, Núm. 2, pp. 225-233

  5. The Lucerne Toolbox 2 to optimise axillary management for early breast cancer: a multidisciplinary expert consensus

    eClinicalMedicine, Vol. 61

2021

  1. Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox

    The Lancet Oncology, Vol. 22, Núm. 1, pp. e18-e28

  2. Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509)

    Journal of Clinical Oncology, Vol. 39, Núm. 20, pp. 2304-2312

  3. SLITRK2, an X-linked modifier of the age at onset in C9orf72 frontotemporal lobar degeneration

    Brain, Vol. 144, Núm. 9, pp. 2798-2811

2020

  1. A Global Survey on the Impact of COVID-19 on Urological Services

    European Urology, Vol. 78, Núm. 2, pp. 265-275

  2. Congenital Uterine Malformation by Experts (CUME): diagnostic criteria for T-shaped uterus

    Ultrasound in Obstetrics and Gynecology, Vol. 55, Núm. 6, pp. 815-829

  3. Exogenous Liposomal Ceramide-C6 Ameliorates Lipidomic Profile, Energy Homeostasis, and Anti-Oxidant Systems in NASH

    Cells, Vol. 9, Núm. 5

  4. Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis

    Scientific Reports, Vol. 10, Núm. 1

  5. Validation of models to diagnose ovarian cancer in patients managed surgically or conservatively: multicentre cohort study

    BMJ (Clinical research ed.), Vol. 370, pp. m2614

2019

  1. Apoptotic caspases inhibit abscopal responses to radiation and identify a new prognostic biomarker for breast cancer patients

    OncoImmunology, Vol. 8, Núm. 11

  2. Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinoma

    Liver International, Vol. 39, Núm. S1, pp. 79-97

  3. Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia

    Scientific Reports, Vol. 9, Núm. 1

  4. Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia

    Nature Medicine, Vol. 25, Núm. 1, pp. 152-164